vimarsana.com

Page 9 - செயல்படுத்துகிறது தொழில்நுட்பங்கள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Globus Medical (GMED) Q4 2020 Earnings Call Transcript

Globus Medical (GMED) Q4 2020 Earnings Call Transcript Motley Fool Transcribing © The Motley Fool Logo of jester cap with thought bubble. Globus Medical (NYSE: GMED) Ladies and gentlemen, thank you for standing by, and welcome to the Globus Medical s fourth quarter and full year 2020 earnings conference call. [Operator instructions] Please be advised that today s conference is being recorded. [Operator instructions] I would now like to hand the conference over to your speaker for today, Brian Kearns, senior vice president of business development and investor relations. Mr. Kearns, please go ahead. Senior Vice President of Business Development and Investor Relations Thank you, Towanda, and thank you, everyone, for being with us today. Joining today s call from Globus Medical will be Dave Demski, president and CEO; Dan Scavilla, executive vice president, chief commercial officer; and Keith Pfeil, senior vice president and chief financial officer. This rev

Neuromorphic Computing Opportunity Analysis 2020: Promising Start-Ups Developing Non-Invasive BCI Solutions Gaining Traction from VC Funds and Tier-1 OEMs – ResearchAndMarkets com

ResearchAndMarkets.com’s offering. Conventional artificial intelligence (AI)-enabled processors are based on rule-based algorithms and are optimized for applications, such as real-time monitoring and reporting. However, with increasing demand for fully autonomous solutions, there is a need for perceptive solutions capable of making probabilistic decisions, replicating the human brain. With technology advancements in chipset architecture and algorithms, neuromorphic chipsets are processing powerhouses that are logically analogous to neurons that exist in biological human brains and efficiently perform complicated decision-making tasks. Neuromorphic computing holds the potential to emerge as a vital breakthrough in applications across the healthcare, manufacturing, and aerospace & defense sectors. With increased funding and related support from government bodies and Tier-1 OEMs, neuromorphic solutions are poised to witness exponential traction from venture capitalists and governme

Data & Racial Equity: How Do We Eliminate Bias from AI, Machine Learning, and More?

Read the Transcript Eric Tischler: Hi, and welcome to The Intersect, I m Eric Tischler. Abt Associates tackles complex challenges around the world, ranging from improving health and education to assessing the impact of environmental changes. For any given problem we bring multiple perspectives to the table. We thought it would be enlightening and maybe even fun to pair colleagues from different disciplines so they can share their ideas and perhaps spark new thinking about how we solve these challenges. Today I m joined by two of those colleagues, Laura Peck and, making his second appearance on The Intersect, Jason Brinkley. Laura is a nationally renowned policy evaluation methodologist who applies her expertise to program areas that include welfare, housing, education, income security, and employment. She currently serves as secretary of the Association for Public Policy Analysis and Management, and is editor of the American Journal of Evaluation s experimental methodology section.

Analysis of Cross Sector Adoption and Ancillary Business Capabilities of Cannabinoids, 2020 Report

Analysis of Cross Sector Adoption and Ancillary Business Capabilities of Cannabinoids, 2020 Report News provided by Share this article Share this article ResearchAndMarkets.com s offering. Cannabinoids as an ingredient for use in pharmaceuticals, F&B, and other industries are steadily gaining in interest across the globe, While R&D and technology developments are on the rise, the industry is still emerging considering the regulatory scenario and the technology limitations. With many technology developers focusing on overcoming challenges and product developmental efforts, new business models need to play with all possible interactions among stakeholders in order to create a smooth environment for commercialization. In countries such as the USA, advancing regulations are encouraging the innovation ecosystem to flourish and new commercialization opportunities are expected to rise in the coming 3-5 years. Competition models are gaining increasing attention in order to face challe

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.